RecruitingPhase 2NCT06913725

An Exploratory Study to Evaluate the Efficacy and Safety of FCN-159 in Patients With Brain Arteriovenous Malformations

Studying Brain arteriovenous malformation

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Xuanwu Hospital, Beijing
Intervention
FCN-159(drug)
Enrollment
10 enrolled
Eligibility
18-60 years · All sexes
Timeline
20252026

Study locations (1)

Collaborators

Shanghai Fosun Pharmaceutical Industry Development Co., Ltd

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06913725 on ClinicalTrials.gov

Other trials for Brain arteriovenous malformation

Additional recruiting or active studies for the same condition.

See all trials for Brain arteriovenous malformation

← Back to all trials